Lisa Guiterman

Media maven, LAX mom, foodie, yoga addict & boot camp devotee, proud @SyracuseU alum

[Luke Timmerman @ldtimmerman]

Biotech in the Balance: Saving a Strategic Industry in an Age of Public Distrust. Listen to @jmaxlevin discuss his new book on The Long Run. Sponsored by: @AlphaSenseInc & Dash Bio. https://t.co/sDIHscoWP6

[Simone Fishburn 🎗️ @FishburnSimone]

Biotech women are calling on industry, FDA to help protect women, employees from the impact of Dobbs. “It’s a human rights issue, a health issue that’s central to our industry and our industry’s effort to improve human health." @juliacowens in @BioCentury https://t.co/l04HSMmChZ

[Lisa Guiterman @LisaG20854]

'Beginning of a broader loss': Pharma execs call regulators and legislators to action four months post-Roe - https://t.co/vMq97IDt2g

[Luke Timmerman @ldtimmerman]

Biotech executives call for action on reproductive health rights. https://t.co/HKqHKuQT9d

[Lisa Guiterman @LisaG20854]

5 Ways the COVID-19 Pandemic Has Changed Our Sex Lives and Relationships via @iamwellandgood https://t.co/DfCXChgrY3

[Lisa Guiterman @LisaG20854]

@potterybarn I guess your Customer Service dead? Blaming that on COVID too? 3rd time my order from 11/20 has been delayed. No proactive comms from @potterybarn. Totally unacceptable.

[Lisa Guiterman @LisaG20854]

Takeda eyes pathway to natural killer therapies, teeing up $100M to partner with KSQ for its CRISPR-screened molecules - https://t.co/dmTGwuUJ6y

[Lisa Guiterman @LisaG20854]

The antibiotic paradox: why companies can’t afford to create life-saving drugs https://t.co/oLdEVG5Bad

[Lisa Guiterman @LisaG20854]

Largest School System in U.S. Cleared to Reopen https://t.co/vAo5Lksyyr

[Lisa Guiterman @LisaG20854]

'This is our moment': Biotech veteran George Scangos is positioning Vir to outflank Covid-19 https://t.co/bkeGckqBdz via @SFBusinessTimes

[Lisa Guiterman @LisaG20854]

Regeneron’s coronavirus treatment might not be cheap, or convenient, but it could be saving lives by fall https://t.co/FYIzAhFBCD via @BW

[Lisa Guiterman @LisaG20854]

Tukysa Approved for Unresectable, Metastatic HER2+ Breast Cancer https://t.co/nsFxV6GPlS

[Lisa Guiterman @LisaG20854]

https://t.co/tjBdSus1RZ

[Linda A. Johnson @LindaJ_onPharma]

The @US_FDA just approved a new drug for an aggressive type of #breastcancer that’s spread, even into the brain. Tukysa is a twice-daily pill developed by Seattle Genetics. It's for people with advanced HER2-positive breast cancer. https://t.co/bAlgUkdHYL

[Lisa Guiterman @LisaG20854]

Vir's Hep B drug, poised for combo trials, shows promise in phase 2 https://t.co/J6MrYZPabh

[Lisa Guiterman @LisaG20854]

GlaxoSmithKline and Vir aim to take on Covid-19 with antibodies and CRISPR https://t.co/KlhD8mthmF via @statnews

[Lisa Guiterman @LisaG20854]

Chinese Scientists Seeking Potential COVID-19 Treatment Find 'Effective' Antibodies https://t.co/USW3meNgN6

[Lisa Guiterman @LisaG20854]

Brii Bio, Tsinghua, Third People’s Hospital to develop COVID-19 patient-derived neutralizing antibodies https://t.co/yCEtzz6vNb

[Lisa Guiterman @LisaG20854]

Brii Bio gets all hands on deck for Covid-19 antibody hunt, leveraging Chinese partners' work with recovered patients - https://t.co/t7UTR7PfuN

[Lisa Guiterman @LisaG20854]

How Monoclonal Antibodies Might Prove Useful Against The Coronavirus https://t.co/4Hsm4dxhfr